Literature DB >> 30113945

Using stratified medicine to understand, diagnose, and treat neuropathic pain.

Andreas C Themistocleous1, Geert Crombez2, Georgios Baskozos1, David L Bennett1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30113945      PMCID： PMC6130809          DOI： 10.1097/j.pain.0000000000001301

Source DB:  PubMed          Journal:  Pain        ISSN： 0304-3959            Impact factor:   7.926


× No keyword cloud information.
  111 in total

1.  Worry and chronic pain: a misdirected problem solving model.

Authors:  Christopher Eccleston; Geert Crombez
Journal:  Pain       Date:  2007-10-24       Impact factor: 6.961

2.  Pronociceptive pain modulation in patients with painful chemotherapy-induced polyneuropathy.

Authors:  Hadas Nahman-Averbuch; David Yarnitsky; Yelena Granovsky; Elliot Sprecher; Mariana Steiner; Tzahala Tzuk-Shina; Dorit Pud
Journal:  J Pain Symptom Manage       Date:  2011-03-31       Impact factor: 3.612

Review 3.  Fear-avoidance and its consequences in chronic musculoskeletal pain: a state of the art.

Authors:  Johan W S Vlaeyen; Steven J Linton
Journal:  Pain       Date:  2000-04       Impact factor: 6.961

4.  The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: a randomised, double-blind, placebo-controlled phenotype-stratified study.

Authors:  Dyveke T Demant; Karen Lund; Jan Vollert; Christoph Maier; Märtha Segerdahl; Nanna B Finnerup; Troels S Jensen; Søren H Sindrup
Journal:  Pain       Date:  2014-08-17       Impact factor: 6.961

5.  Gain of function Naν1.7 mutations in idiopathic small fiber neuropathy.

Authors:  Catharina G Faber; Janneke G J Hoeijmakers; Hye-Sook Ahn; Xiaoyang Cheng; Chongyang Han; Jin-Sung Choi; Mark Estacion; Giuseppe Lauria; Els K Vanhoutte; Monique M Gerrits; Sulayman Dib-Hajj; Joost P H Drenth; Stephen G Waxman; Ingemar S J Merkies
Journal:  Ann Neurol       Date:  2011-06-22       Impact factor: 10.422

6.  Small fibre pathology in patients with fibromyalgia syndrome.

Authors:  Nurcan Üçeyler; Daniel Zeller; Ann-Kathrin Kahn; Susanne Kewenig; Sarah Kittel-Schneider; Annina Schmid; Jordi Casanova-Molla; Karlheinz Reiners; Claudia Sommer
Journal:  Brain       Date:  2013-03-09       Impact factor: 13.501

7.  EFNS guidelines on neuropathic pain assessment.

Authors:  G Cruccu; P Anand; N Attal; L Garcia-Larrea; M Haanpää; E Jørum; J Serra; T S Jensen
Journal:  Eur J Neurol       Date:  2004-03       Impact factor: 6.089

8.  Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial.

Authors:  Nadine Attal; Daniel C de Andrade; Frédéric Adam; Danièle Ranoux; Manoel J Teixeira; Ricardo Galhardoni; Irina Raicher; Nurcan Üçeyler; Claudia Sommer; Didier Bouhassira
Journal:  Lancet Neurol       Date:  2016-03-02       Impact factor: 44.182

9.  Novel mutations mapping to the fourth sodium channel domain of Nav1.7 result in variable clinical manifestations of primary erythromelalgia.

Authors:  Roman Cregg; Bisola Laguda; Robert Werdehausen; James J Cox; John E Linley; Juan D Ramirez; Istvan Bodi; Michael Markiewicz; Kevin J Howell; Ya-Chun Chen; Karen Agnew; Henry Houlden; Michael P Lunn; David L H Bennett; John N Wood; Maria Kinali
Journal:  Neuromolecular Med       Date:  2013-01-06       Impact factor: 3.843

10.  Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors.

Authors:  Stuart M Chambers; Yuchen Qi; Yvonne Mica; Gabsang Lee; Xin-Jun Zhang; Lei Niu; James Bilsland; Lishuang Cao; Edward Stevens; Paul Whiting; Song-Hai Shi; Lorenz Studer
Journal:  Nat Biotechnol       Date:  2012-07-01       Impact factor: 54.908
View more
  16 in total

Review 1.  Biological predictors of chemotherapy-induced peripheral neuropathy (CIPN): MASCC neurological complications working group overview.

Authors:  Alexandre Chan; Daniel L Hertz; Manuel Morales; Elizabeth J Adams; Sharon Gordon; Chia Jie Tan; Nathan P Staff; Jayesh Kamath; Jeong Oh; Shivani Shinde; Doreen Pon; Niharkia Dixit; James D'Olimpio; Cristina Dumitrescu; Margherita Gobbo; Kord Kober; Samantha Mayo; Linda Pang; Ishwaria Subbiah; Andreas S Beutler; Katherine B Peters; Charles Loprinzi; Maryam B Lustberg
Journal:  Support Care Cancer       Date:  2019-07-30       Impact factor: 3.603

2.  Progress in pain medicine: where are we now?

Authors:  Lesley A Colvin; Andrew S C Rice
Journal:  Br J Anaesth       Date:  2019-06-04       Impact factor: 9.166

3.  The Novel Activity of Carbamazepine as an Activation Modulator Extends from NaV1.7 Mutations to the NaV1.8-S242T Mutant Channel from a Patient with Painful Diabetic Neuropathy.

Authors:  Chongyang Han; Andreas C Themistocleous; Mark Estacion; Fadia B Dib-Hajj; Iulia Blesneac; Lawrence Macala; Carl Fratter; David L Bennett; Stephen G Waxman; Sulayman D Dib-Hajj
Journal:  Mol Pharmacol       Date:  2018-08-22       Impact factor: 4.436

4.  Co-occurrence and metabolic biomarkers of sensory and motor subtypes of peripheral neuropathy from paclitaxel.

Authors:  Ciao-Sin Chen; Ellen M Lavoie Smith; Kathleen A Stringer; N Lynn Henry; Daniel L Hertz
Journal:  Breast Cancer Res Treat       Date:  2022-06-28       Impact factor: 4.624

5.  Contribution of COMT and BDNF Genotype and Expression to the Risk of Transition From Acute to Chronic Low Back Pain.

Authors:  Kyle M Baumbauer; Divya Ramesh; Mallory Perry; Katherine B Carney; Thomas Julian; Nicole Glidden; Susan G Dorsey; Angela R Starkweather; Erin E Young
Journal:  Clin J Pain       Date:  2020-06       Impact factor: 3.442

Review 6.  Navigating trials of personalized pain treatments: we're going to need a bigger boat.

Authors:  Jennifer S Gewandter; Michael P McDermott; Omar Mbowe; Robert R Edwards; Nathaniel P Katz; Dennis C Turk; Robert H Dworkin
Journal:  Pain       Date:  2019-06       Impact factor: 7.926

Review 7.  Chemotherapy-induced peripheral neuropathy: where are we now?

Authors:  Lesley A Colvin
Journal:  Pain       Date:  2019-05       Impact factor: 7.926

8.  An introduction to the Biennial Review of Pain.

Authors:  Michael S Gold
Journal:  Pain       Date:  2018-09       Impact factor: 7.926

Review 9.  New Perspective in Diabetic Neuropathy: From the Periphery to the Brain, a Call for Early Detection, and Precision Medicine.

Authors:  Heng Yang; Gordon Sloan; Yingchun Ye; Shuo Wang; Bihan Duan; Solomon Tesfaye; Ling Gao
Journal:  Front Endocrinol (Lausanne)       Date:  2020-01-17       Impact factor: 5.555

Review 10.  Risks of harm with cannabinoids, cannabis, and cannabis-based medicine for pain management relevant to patients receiving pain treatment: protocol for an overview of systematic reviews.

Authors:  Ian Gilron; Fiona M Blyth; Louisa Degenhardt; Marta Di Forti; Christopher Eccleston; Simon Haroutounian; Andrew Moore; Andrew S C Rice; Mark Wallace
Journal:  Pain Rep       Date:  2019-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.